Does Helicobacter pylori eradication prevent gastric cancer? [1]

Digestive and Liver Disease

Volumn 33, Issue 9, 2001, Pages 803-804

  Fallone, C A ^a   Barkun, A N ^a   Halwani, F ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; TETRACYCLINE;

ADULT; BREATH ANALYSIS; CANCER GROWTH; CASE REPORT; CHRONIC GASTRITIS; ERADICATION THERAPY; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; LETTER; MALE; PARTIAL GASTRECTOMY; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; STOMACH CANCER;

EID: 0035695196     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(01)80699-X     Document Type: Letter

References (8)

1. An international association between Helicobacter pylori and gastric cancer
2. Reversal of fundic atrophy after eradication of Helicobacter pylori
3. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated
4. Gastric markers of pre-malignancy are not reversible
5. Participants of the International Workshop on the Histopathology of Gastritis. Classification and grading of gastritis: The updated Sydney System
6. Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma
7. Helicobacter pylori and gastric cancer
8. Development of early gastric cancer 4 years after remission of Helicobacter pylori-associated gastric low grade B-Cell MALT lymphoma